The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by tumor-vascular disrupting agents
DW Siemann - Cancer treatment reviews, 2011 - Elsevier
The vasculature of solid tumors is fundamentally different from that of normal vasculature
and offers a unique target for anti-cancer therapy. Direct vascular-targeting with Tumor-…
and offers a unique target for anti-cancer therapy. Direct vascular-targeting with Tumor-…
Vascular‐targeting therapies for treatment of malignant disease
DW Siemann, DJ Chaplin, MR Horsman - Cancer, 2004 - Wiley Online Library
BACKGROUND Tumor endothelium represents a valuable target for cancer therapy. The
vasculature plays a critical role in the survival and continued growth of solid tumor masses; in …
vasculature plays a critical role in the survival and continued growth of solid tumor masses; in …
Differentiation and definition of vascular-targeted therapies
The therapeutic potential of targeting the tumor vascular supply is now widely recognized.
Intense research and development activity has resulted in a variety of investigational agents, a …
Intense research and development activity has resulted in a variety of investigational agents, a …
A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P)
DW Siemann, DJ Chaplin… - Expert opinion on …, 2009 - Taylor & Francis
Vascular-disrupting strategies impair a tumor's blood vessel network, which is essential for
tumor progression and metastasis. Vascular-disrupting agents (VDAs) cause a rapid and …
tumor progression and metastasis. Vascular-disrupting agents (VDAs) cause a rapid and …
Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies
MR Horsman, DW Siemann - Cancer research, 2006 - AACR
A functional vascular supply is critical for the continued growth and development of solid
tumors. It also plays a major role in metastatic spread of tumor cells. This importance has led to …
tumors. It also plays a major role in metastatic spread of tumor cells. This importance has led to …
Cathepsin L targeting in cancer treatment
DR Sudhan, DW Siemann - Pharmacology & therapeutics, 2015 - Elsevier
Proteolytic enzymes may serve as promising targets for novel therapeutic treatment strategies
seeking to impede cancer progression and metastasis. One such enzyme is cathepsin L (…
seeking to impede cancer progression and metastasis. One such enzyme is cathepsin L (…
Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise
…, JN Stabley, DW Siemann… - Journal of the …, 2014 - academic.oup.com
Background Previous studies have hypothesized that tumor blood flow may be elevated or
reduced during exercise, which could impact the tumor microenvironment. However, to date …
reduced during exercise, which could impact the tumor microenvironment. However, to date …
Modulation of the tumor vasculature and oxygenation to improve therapy
DW Siemann, MR Horsman - Pharmacology & therapeutics, 2015 - Elsevier
The tumor microenvironment is increasingly recognized as a major factor influencing the
success of therapeutic treatments and has become a key focus for cancer research. The …
success of therapeutic treatments and has become a key focus for cancer research. The …
Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells
…, DA Steindler, J Vieweg, DW Siemann - The Journal of …, 2010 - auajournals.org
Purpose : We identified a discrete population of stem cell-like tumor cells expressing 5 essential
transcription factors required to reprogram pluripotency in prostate tumor cell lines and …
transcription factors required to reprogram pluripotency in prostate tumor cell lines and …
Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.
C Teschendorf, KH Warrington Jr, DW Siemann… - Anticancer …, 2002 - europepmc.org
BACKGROUND: Silencing of the viral CMV immediate early enhancer promoter can be a
problem in certain cell types when engineering stable cell lines. MATERIALS AND METHODS: …
problem in certain cell types when engineering stable cell lines. MATERIALS AND METHODS: …